Medical Policy Revision: BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Effective August 29, 2019, Horizon BCBSNJ will change the way we consider certain professional claims based on revisions to our medical policy BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia.
Access our Medical Policy Manual to review this medical policy content.
Claims submitted for services provided on and after August 29, 2019 to patients enrolled in Horizon BCBSNJ commercial or Administrative Services Only (ASO) plans will be processed as follows.
- Regardless of the submitted diagnosis code(s), information will be requested to help us determine the medical appropriateness of the services represented by CPT® code 81403. Following our review of medical record information, these services may be denied as not medically necessary.
Unless Horizon BCBSNJ gives written notice that all or part of the above changes have been canceled or postponed, the changes will be applied to claims for dates of service on and after August 29, 2019.
CPT® is a registered mark of the American Medical Association.